Q3 2023 · 13F-HR/A
Birchview Capital, LPholdings as filed
Filed 2025-06-30 · accession 0001618205-25-000003
$117.7M
Reported value
51
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $41.6M | 35.3% | 716,297 | Common | SOLE |
| 09075X108 | — | BIODESIX INC COM RST | $8.7M | 7.43% | 5,348,273 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $8.7M | 7.38% | 77,240 | Common | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $8.2M | 6.95% | 169,574 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $5.0M | 4.26% | 240,400 | Common | SOLE |
| 74838J101 | — | QUIDELORTHO CORP | $4.8M | 4.05% | 65,203 | Common | SOLE |
| 69047Q102 | OVV | OVINTIV INC | $4.0M | 3.40% | 84,200 | Common | SOLE |
| 45253H101 | IMGNEUR | IMMUNOGEN INC | $3.0M | 2.56% | 190,000 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP | $2.5M | 2.11% | 11,000 | Common | SOLE |
| 05479K106 | ELUT | ELUTIA INC | $2.4M | 2.01% | 1,655,184 | Common | SOLE |
| 415858109 | HROW | HARROW HEALTH INC | $2.2M | 1.83% | 150,000 | Common | SOLE |
| 71944F106 | PHR | PHREESIA INC | $1.5M | 1.31% | 82,700 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $1.4M | 1.19% | 50,000 | Common | SOLE |
| 09609G100 | — | BLUEBIRD BIO INC | $1.4M | 1.18% | 455,200 | Common | SOLE |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $1.4M | 1.16% | 50,000 | Common | SOLE |
| 574795100 | MASI | MASIMO CORP | $1.3M | 1.14% | 15,280 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $1.3M | 1.12% | 264,843 | Common | SOLE |
| 00430H102 | — | ACCELERATE DIAGNOSTICS INC | $1.3M | 1.10% | 225,239 | Common | SOLE |
| 45720L107 | INBXUSD | INHIBRX INC | $1.3M | 1.10% | 70,448 | Common | SOLE |
| 294600101 | ETRNUSD | EQUITRANS MIDSTREAM CORPORATIO | $1.2M | 1.06% | 133,050 | Common | SOLE |
| 02081G201 | ATEC | ALPHATEC HOLDINGS INC | $1.0M | 0.88% | 80,000 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $916,872 | 0.78% | 26,400 | Common | SOLE |
| 723787107 | PXDEUR | PIONEER NATURAL RESOURCES CO | $872,290 | 0.74% | 3,800 | Common | SOLE |
| 88025U109 | TXG | 10X GENOMICS INC | $866,250 | 0.74% | 21,000 | Common | SOLE |
| 05463X106 | AXGN | AXOGEN INC | $865,000 | 0.73% | 173,000 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $766,255 | 0.65% | 571,832 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $736,500 | 0.63% | 25,000 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $733,080 | 0.62% | 82,000 | Common | SOLE |
| 256086109 | DCGO | DOCGO INC | $692,900 | 0.59% | 130,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $684,720 | 0.58% | 18,000 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $633,840 | 0.54% | 38,000 | Common | SOLE |
| 82710M100 | SILKUSD | SILK ROAD MEDICAL INC | $618,997 | 0.53% | 41,294 | Common | SOLE |
| 74340E103 | PGNY | PROGYNY INC | $612,360 | 0.52% | 18,000 | Common | SOLE |
| G5269C101 | — | KINIKSA PHARMACEUTICALS LTD | $521,100 | 0.44% | 30,000 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $385,200 | 0.33% | 40,000 | Common | SOLE |
| 40637H109 | HALO | HALOZYME THERAPEUTICS INC | $382,000 | 0.32% | 10,000 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $341,600 | 0.29% | 10,000 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $340,480 | 0.29% | 28,000 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $334,900 | 0.28% | 85,000 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $303,050 | 0.26% | 2,500 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $294,600 | 0.25% | 15,000 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $247,845 | 0.21% | 12,300 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $234,545 | 0.20% | 59,833 | Common | SOLE |
| 230031106 | CGEM | CULLINAN ONCOLOGY INC | $227,282 | 0.19% | 25,114 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $223,160 | 0.19% | 7,000 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $174,128 | 0.15% | 209,088 | Common | SOLE |
| 3621LQ109 | GTHXEUR | G1 THERAPEUTICS INC | $172,800 | 0.15% | 120,000 | Common | SOLE |
| N44821101 | IFRX | INFLARX NV | $149,000 | 0.13% | 50,000 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $141,600 | 0.12% | 20,000 | Common | SOLE |
| 640268108 | NKTREUR | NEKTAR THERAPEUTICS | $16,677 | 0.01% | 28,000 | Common | SOLE |
| 98585K102 | — | YIELD10 BIOSCIENCE INC | $6,126 | 0.01% | 18,750 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.